TA
GSK icon

Tectonic Advisors’s GSK GSK Stock Holding History

Tectonic Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,600
Closed -$279K – 221
2021
Q2 		$279K Hold
5,600
– – 0.06% 154
2021
Q1 		$250K Sell
5,600
-443
-7% -$20.1K 0.06% 144
2020
Q4 		$278K Buy
+6,043
New +$278K 0.08% 133

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tectonic Advisors's GSK Position: Q3 2021 in Review

Tectonic Advisors sold out of GSK (GSK) in Q3 2021, closing a stake of 5,600 shares — an estimated $279K sold.

Tectonic Advisors first reported a position in GSK in Q4 2020 and held it in 3 quarters. The position peaked at $279K in Q2 2021. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Tectonic Advisors reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
  • Tectonic Advisors sold 5,600 GSK shares in Q3 2021, an estimated $279K.
  • Tectonic Advisors first reported a position in GSK in Q4 2020 and held it in 3 quarters.
  • Tectonic Advisors's GSK position peaked at $279K in Q2 2021.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Tectonic Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.